Sign inJoin waitlistJoin the waitlist

Martha Mims

Professor and Chief · Baylor College of Medicine

Credentials: · · · · ·

History

Baylor College of Medicine
Present
Clinical Trial Support Unit · Baylor College of Medicine
Present
Hematology and Oncology Division · Robert Larner College of Medicine
Present

Baylor College of Medicine
2001–2004
Baylor St. Luke's Medical Center
1998–2001
Baylor College of Medicine
1994–1998

Research

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients
Journal of Clinical Investigation · 2011 · 860 citations
A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells
Gene Therapy · 1996 · 200 citations
Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload
Case report · Blood · 2005 · First of 8 authors · 161 citations

GR
Gustavo Rivero
9 papers
MI
Michael Ittmann
7 papers
TH
Teresa Hayes
6 papers
Courtney Miller-Chism
5 papers
Helen Heslop
5 papers
Josef Prchal
5 papers
MU
Mark Udden
5 papers · 2 as a resident
RK
Rammurti Kamble
5 papers
TW
Thomas Wheeler
5 papers
DK
Dov Kadmon
4 papers
Malcolm Brenner
4 papers
Sarvari Yellapragada
4 papers

Grants

Baylor College of Medicine Cancer Center - Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $3.8M · Baylor College of Medicine
2007–2030
OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System
National Cancer Institute · R01
PI · $3.7M · Thomas Jefferson University
2021–2027
DMT1:Tissue Specific Expression & Alternative Splicing
National Institute of Diabetes and Digestive and Kidney Diseases · R21
Contact PI · $296.5K · Baylor College of Medicine
2005–2008
Dynamics of Apoe Binding to Lipoproteins and Receptors
National Heart, Lung, and Blood Institute · R01
Contact PI · $843.9K · Baylor College of Medicine
1993–1999

Clinical trials

Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population
Principal investigator · Active not recruiting · Phase 2
Baylor College of Medicine
2020–2028
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer
Principal investigator · Recruiting · Phase 2
Martha Mims
2019–2038
Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
Principal investigator · Terminated · Phase 1
Baylor College of Medicine
2013–2015
A Study of Bevacizumab to Prevent Malignant Ascites
Principal investigator · Withdrawn · Phase 2
Baylor College of Medicine
2009–2011